Home Cart 0 Sign in  
X

[ CAS No. 34626-51-2 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 34626-51-2
Chemical Structure| 34626-51-2
Chemical Structure| 34626-51-2
Structure of 34626-51-2 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 34626-51-2 ]

Related Doc. of [ 34626-51-2 ]

Alternatived Products of [ 34626-51-2 ]

Product Details of [ 34626-51-2 ]

CAS No. :34626-51-2 MDL No. :MFCD00061101
Formula : C5H11BrO Boiling Point : -
Linear Structure Formula :- InChI Key :WJVQJXVMLRGNGA-UHFFFAOYSA-N
M.W : 167.04 Pubchem ID :118709
Synonyms :

Calculated chemistry of [ 34626-51-2 ]

Physicochemical Properties

Num. heavy atoms : 7
Num. arom. heavy atoms : 0
Fraction Csp3 : 1.0
Num. rotatable bonds : 4
Num. H-bond acceptors : 1.0
Num. H-bond donors : 1.0
Molar Refractivity : 35.18
TPSA : 20.23 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.35 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.98
Log Po/w (XLOGP3) : 1.37
Log Po/w (WLOGP) : 1.54
Log Po/w (MLOGP) : 1.71
Log Po/w (SILICOS-IT) : 1.53
Consensus Log Po/w : 1.63

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.47
Solubility : 5.6 mg/ml ; 0.0335 mol/l
Class : Very soluble
Log S (Ali) : -1.4
Solubility : 6.69 mg/ml ; 0.04 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.17
Solubility : 1.12 mg/ml ; 0.00671 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.39

Safety of [ 34626-51-2 ]

Signal Word:Danger Class:3
Precautionary Statements:P210-P233-P240-P241-P242-P243-P261-P264-P270-P271-P280-P301+P312+P330-P303+P361+P353-P304+P340+P312-P305+P351+P338+P310-P332+P313-P370+P378-P403+P233-P403+P235-P405-P501 UN#:1993
Hazard Statements:H226-H302-H315-H318-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 34626-51-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 34626-51-2 ]
  • Downstream synthetic route of [ 34626-51-2 ]

[ 34626-51-2 ] Synthesis Path-Upstream   1~14

  • 1
  • [ 34626-51-2 ]
  • [ 954-81-4 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2014, vol. 22, # 17, p. 4602 - 4608
  • 2
  • [ 34626-51-2 ]
  • [ 2695-47-8 ]
Reference: [1] RSC Advances, 2015, vol. 5, # 37, p. 29114 - 29120
  • 3
  • [ 34626-51-2 ]
  • [ 407-97-6 ]
Reference: [1] Chemistry and Biology, 2010, vol. 17, # 1, p. 18 - 27
  • 4
  • [ 111-29-5 ]
  • [ 34626-51-2 ]
YieldReaction ConditionsOperation in experiment
89.1% With hydrogen bromide In benzene at 70 - 80℃; for 15 h; In 250mL three-necked flask add 1a (14 g, 0.135 mol), 40percent hydrobromic acid (28 mL, 0.2 mol) and 60 mL of benzene, 70 ~ 80 ° C oil bath water for 15h, TLC detection, raw material points disappear. Washed successively with 5percent sodium hydroxide solution, 10percent hydrochloric acid and saturated brine, and dried over anhydrous sodium sulfate. The crude product was separated by silica gel column chromatography (petroleum ether: ethyl acetate, V / V = 8: 1) and concentrated to give colorless to pale yellow liquid 2a (20.1g, yield 89.1percent).
80% With hydrogen bromide In water; toluene for 15 h; Dean-Stark; Reflux A round bottom flask, equipped with a Dean-Stark trap, wascharged with 1,5-pentanediol (3.71 g, 35.6 mmol), concentratedhydrobromic acid (5 mL), and toluene (75 mL). The mixture wasstirred under refluxed for 15 h. After cooling, the reaction mixturewas extracted with 6 M sodium hydroxide (2 15 mL), 5percent HCl(2 15 mL), water (2 15 mL) and brine (20 mL). The organicswere dried over sodium sulfate and concentrated under reducedpressure to yield the title compound as an orange/brown oil(4.75 g, 2.84 mmol, 801H NMR (500 MHz, CDCl3) d 8.16(s, 1H), 7.65 (s, 1H), 7.46 (m, 6H), 7.25 (m 6H), 7.17 (m, 3H), 6.98(m, 3H), 6.48 (m, 4H), 3.59 (br, 2H), 3.11 (br, 4H), 2.65 (q, 12H,J = 7 Hz), 2.11 (br, 2H), 1.61 (m, 2H), 1.52 (m, 4H), 1.45 (m, 2H),1.41 (s, 9H), 1.31 (m, 2H), 1.01 (t, 18H, J = 7 Hz); 13C NMR(125 MHz, CDCl3) d 180.65, 171.21, 156.78, 155.79, 155.64, 146.13,140.35, 138.09, 130.98, 129.19, 128.54, 127.72, 126.14, 124.68,123.33, 120.15, 113.95, 103.13, 79.37, 79.15, 70.77, 47.23, 46.91,45.71, 44.64, 43.29, 29.65, 28.48, 28.14, 27.81, 26.53, 26.10,24.21, 9.07; HRMS (C54H56N4O7S): calculated 904.3870, observed904.3866.
Reference: [1] Patent: CN105766907, 2016, A, . Location in patent: Paragraph 0026; 0041; 0042
[2] RSC Advances, 2015, vol. 5, # 37, p. 29114 - 29120
[3] Chemistry - A European Journal, 2015, vol. 21, # 30, p. 10721 - 10728
[4] Journal of Physical Chemistry, 1995, vol. 99, # 32, p. 12195 - 12203
[5] Organic Process Research and Development, 2003, vol. 7, # 3, p. 339 - 340
[6] Bioorganic and Medicinal Chemistry, 2014, vol. 22, # 17, p. 4602 - 4608
[7] Synthesis, 1985, # 12, p. 1161 - 1162
[8] Synthetic Communications, 2003, vol. 33, # 10, p. 1809 - 1814
[9] Tetrahedron Letters, 2002, vol. 43, # 2, p. 327 - 329
[10] Tetrahedron, 2005, vol. 61, # 5, p. 1127 - 1140
[11] Tetrahedron Letters, 1996, vol. 37, # 5, p. 625 - 628
[12] Canadian Journal of Chemistry, 1994, vol. 72, # 6, p. 1500 - 1511
[13] Journal of Agricultural and Food Chemistry, 2004, vol. 52, # 14, p. 4368 - 4374
[14] Journal of the American Chemical Society, 2013, vol. 135, # 32, p. 11692 - 11695
[15] Advanced Synthesis and Catalysis, 2000, vol. 342, # 8, p. 779 - 784
[16] Tetrahedron Letters, 1988, vol. 29, # 48, p. 6369 - 6372
[17] Tetrahedron, 1991, vol. 47, # 18, p. 3095 - 3128
[18] Synthetic Communications, 1989, vol. 19, # 7,8, p. 1369 - 1380
[19] Bioscience, Biotechnology, and Biochemistry, 1992, vol. 56, # 12, p. 1962 - 1965
[20] Agricultural and Biological Chemistry, 1985, vol. 49, # 1, p. 141 - 148
[21] Journal of Organic Chemistry, 1997, vol. 62, # 26, p. 9192 - 9202
[22] Bulletin de la Societe Chimique de France, 1994, vol. 131, # 6, p. 699 - 705
[23] Journal of Organic Chemistry, 1995, vol. 60, # 10, p. 2989 - 2999
[24] Synthetic Communications, 2007, vol. 37, # 15, p. 2491 - 2500
[25] Tetrahedron, 2010, vol. 66, # 6, p. 1267 - 1273
[26] Chemical Papers, 2015, vol. 69, # 2, p. 380 - 384
[27] Patent: CN105732654, 2016, A, . Location in patent: Paragraph 0067; 0068
[28] Patent: CN103102266, 2016, B, . Location in patent: Paragraph 0024
  • 5
  • [ 142-68-7 ]
  • [ 34626-51-2 ]
Reference: [1] Tetrahedron Letters, 1996, vol. 37, # 38, p. 6919 - 6922
[2] Journal of Organic Chemistry, 1987, vol. 52, # 9, p. 1680 - 1686
[3] Journal of Organic Chemistry, 2002, vol. 67, # 26, p. 9248 - 9256
[4] Organic Process Research and Development, 2003, vol. 7, # 3, p. 339 - 340
[5] Synthetic Communications, 1989, vol. 19, # 13-14, p. 2431 - 2440
[6] Heterocycles, 1982, vol. 18, p. 163 - 167
[7] Journal of Organic Chemistry, 1993, vol. 58, # 25, p. 7170 - 7179
[8] Synthesis, 1992, # 12, p. 1239 - 1241
[9] Justus Liebigs Annalen der Chemie, 1970, vol. 738, p. 170 - 173
[10] Journal of Organic Chemistry, 2016, vol. 81, # 16, p. 7288 - 7300
  • 6
  • [ 15848-22-3 ]
  • [ 34626-51-2 ]
Reference: [1] Journal of the Chemical Society - Perkin Transactions 1, 1999, # 19, p. 2771 - 2782
[2] Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry, 1989, vol. 28, # 1-11, p. 728 - 732
[3] Synthesis, 1992, # 12, p. 1239 - 1241
[4] Canadian Journal of Chemistry, 1992, vol. 70, # 5, p. 1427 - 1445
[5] Justus Liebigs Annalen der Chemie, 1970, vol. 738, p. 170 - 173
[6] Tetrahedron, 1971, vol. 27, p. 5979 - 5985
[7] Journal of the Chemical Society, 1963, p. 4363 - 4368
[8] Synthetic Communications, 1989, vol. 19, # 3and4, p. 645 - 658
[9] Bioscience, Biotechnology, and Biochemistry, 1992, vol. 56, # 12, p. 1962 - 1965
[10] Journal of Organic Chemistry, 1993, vol. 58, # 25, p. 7170 - 7179
[11] Patent: US5866560, 1999, A,
  • 7
  • [ 2067-33-6 ]
  • [ 34626-51-2 ]
Reference: [1] Journal of the American Chemical Society, 1996, vol. 118, # 50, p. 12541 - 12554
[2] Helvetica Chimica Acta, 1993, vol. 76, p. 1901 - 1915
[3] Farmaco, 1992, vol. 47, # 3, p. 379 - 385
[4] Bulletin of the Chemical Society of Japan, 2005, vol. 78, # 10, p. 1856 - 1861
  • 8
  • [ 14660-52-7 ]
  • [ 34626-51-2 ]
Reference: [1] Monatshefte fur Chemie, 1998, vol. 129, # 8-9, p. 931 - 936
[2] Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences, 1959, vol. 248, p. 2217
[3] Helvetica Chimica Acta, 1993, vol. 76, p. 1901 - 1915
  • 9
  • [ 5454-83-1 ]
  • [ 34626-51-2 ]
Reference: [1] Synthetic Communications, 1996, vol. 26, # 6, p. 1143 - 1147
[2] Synthesis, 1991, # 8, p. 641 - 643
  • 10
  • [ 111-29-5 ]
  • [ 111-24-0 ]
  • [ 34626-51-2 ]
Reference: [1] Journal of Organic Chemistry, 2000, vol. 65, # 18, p. 5837 - 5838
  • 11
  • [ 14660-52-7 ]
  • [ 7664-93-9 ]
  • [ 34626-51-2 ]
Reference: [1] Patent: US4971987, 1990, A,
  • 12
  • [ 15848-22-3 ]
  • [ 7664-93-9 ]
  • [ 34626-51-2 ]
Reference: [1] Patent: US6677324, 2004, B1,
  • 13
  • [ 142-68-7 ]
  • [ 110-87-2 ]
  • [ 34626-51-2 ]
Reference: [1] Journal of Organic Chemistry, 1997, vol. 62, # 26, p. 9192 - 9202
  • 14
  • [ 34626-51-2 ]
  • [ 54512-75-3 ]
Reference: [1] Journal of Physical Chemistry, 1995, vol. 99, # 32, p. 12195 - 12203
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 34626-51-2 ]

Aliphatic Chain Hydrocarbons

Chemical Structure| 4457-67-4

[ 4457-67-4 ]

1-Bromo-4-methoxybutane

Similarity: 0.76

Chemical Structure| 3344-70-5

[ 3344-70-5 ]

1,12-Dibromododecane

Similarity: 0.71

Chemical Structure| 693-58-3

[ 693-58-3 ]

1-Bromononane

Similarity: 0.71

Chemical Structure| 4101-68-2

[ 4101-68-2 ]

1,10-Dibromodecane

Similarity: 0.71

Chemical Structure| 112-82-3

[ 112-82-3 ]

1-Bromohexadecane

Similarity: 0.71

Bromides

Chemical Structure| 4457-67-4

[ 4457-67-4 ]

1-Bromo-4-methoxybutane

Similarity: 0.76

Chemical Structure| 3344-70-5

[ 3344-70-5 ]

1,12-Dibromododecane

Similarity: 0.71

Chemical Structure| 693-58-3

[ 693-58-3 ]

1-Bromononane

Similarity: 0.71

Chemical Structure| 4101-68-2

[ 4101-68-2 ]

1,10-Dibromodecane

Similarity: 0.71

Chemical Structure| 112-82-3

[ 112-82-3 ]

1-Bromohexadecane

Similarity: 0.71

Alcohols

Chemical Structure| 627-18-9

[ 627-18-9 ]

3-Bromopropan-1-ol

Similarity: 0.67

Chemical Structure| 19812-64-7

[ 19812-64-7 ]

Tetradecane-1,14-diol

Similarity: 0.64

Chemical Structure| 112-92-5

[ 112-92-5 ]

1-Hydroxyoctadecane

Similarity: 0.64

Chemical Structure| 1454-85-9

[ 1454-85-9 ]

Heptadecan-1-ol

Similarity: 0.64

Chemical Structure| 112-47-0

[ 112-47-0 ]

1,10-Decanediol

Similarity: 0.64